Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;20(6):835-46.
doi: 10.1007/s10552-009-9323-1. Epub 2009 Mar 11.

Sweets, Sweetened Beverages, and Risk of Pancreatic Cancer in a Large Population-Based Case-Control Study

Free PMC article

Sweets, Sweetened Beverages, and Risk of Pancreatic Cancer in a Large Population-Based Case-Control Study

June M Chan et al. Cancer Causes Control. .
Free PMC article


Objective: We examined the associations between sweets, sweetened and unsweetened beverages, and sugars and pancreatic cancer risk.

Methods: We conducted a population-based case-control study (532 cases, 1,701 controls) and used multivariate logistic regression models to calculate odds ratios (OR) and 95% confidence intervals (CI). Because associations were often different by sex, we present results for men and women combined and separately.

Results: Among men, greater intakes of total and specific sweets were associated with pancreatic cancer risk (total sweets: OR = 1.9, 95% CI: 1.0, 3.6; sweet condiments: OR = 1.9, 95% CI: 1.2, 3.1; chocolate candy: OR = 2.4, 95% CI: 1.1, 5.0; other mixed candy bars: OR = 3.3, 95% CI: 1.5, 7.3 for 1 + servings/day versus none/rarely). Sweets were not consistently associated with risk among women. Sweetened beverages were not associated with increased pancreatic cancer risk. In contrast, low-calorie soft drinks were associated with increased risk among men only; while other low-/non-caloric beverages (e.g., coffee, tea, and water) were unassociated with risk. Of the three sugars assessed (lactose, fructose, and sucrose), only the milk sugar lactose was associated with pancreatic cancer risk (OR = 2.0, 95% CI: 1.5, 2.7 comparing extreme quartiles).

Conclusion: These results provide limited support for the hypothesis that sweets or sugars increase pancreatic cancer risk.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles


    1. American Cancer Society. Cancer facts and figures—2008. Atlanta, GA: American Cancer Society; 2008 Contract No.: Document Number
    1. {'text': '', 'index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/sj.bjc.6602619', 'is_inner': False, 'url': ''}, {'type': 'PMC', 'value': 'PMC2361795', 'is_inner': False, 'url': ''}, {'type': 'PubMed', 'value': '15886696', 'is_inner': True, 'url': ''}]}
    2. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083. doi:10.1038/sj.bjc.6602619 - PMC - PubMed
    1. {'text': '', 'index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/sj.bjc.6603571', 'is_inner': False, 'url': ''}, {'type': 'PMC', 'value': 'PMC2360024', 'is_inner': False, 'url': ''}, {'type': 'PubMed', 'value': '17224924', 'is_inner': True, 'url': ''}]}
    2. Stevens RJ, Roddam AW, Beral V (2007) Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 96(3):507–509. doi:10.1038/sj.bjc.6603571 - PMC - PubMed
    1. {'text': '', 'index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.294.22.2872', 'is_inner': False, 'url': ''}, {'type': 'PubMed', 'value': '16352795', 'is_inner': True, 'url': ''}]}
    2. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872–2878. doi:10.1001/jama.294.22.2872 - PubMed
    1. {'text': '', 'index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.283.19.2552', 'is_inner': False, 'url': ''}, {'type': 'PubMed', 'value': '10815119', 'is_inner': True, 'url': ''}]}
    2. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283(19):2552–2558. doi:10.1001/jama.283.19.2552 - PubMed

Publication types

MeSH terms